F

Fabrus

2 employees

Fabrus identifies and develops functional therapeutic monoclonal antibodies to challenging cell surface targets like GPCRs and ion channels.

Basic info

Industry

biotechnology

Sectors

Biotechnology
Pharmaceutical
Therapeutics

Date founded

2007

Funding rounds raised

Total raised

$2M

from 1 investors over 1 rounds

F

Fabrus raised $2M on November 4, 2010

Investors: OPKO Health, Inc.

FAQ